| JNJ | 3.30% | 155.17 | -1.05% | 10,431 | |
| JPM | 3.19% | 286.55 | -0.74% | 5,929 | |
| XOM | 3.17% | 112.91 | -0.89% | 15,225 | |
| VZ | 2.64% | 41.26 | -0.77% | 29,489 | |
| CVX | 2.56% | 150.69 | -0.63% | 9,208 | |
| PFE | 2.32% | 24.61 | -2.92% | 48,593 | |
| CMCSA | 2.32% | 34.72 | -2.58% | 33,009 | |
| QCOM | 2.27% | 154.30 | +0.01% | 7,668 | |
| BAC | 2.19% | 46.15 | -1.95% | 24,384 | |
| MRK | 2.18% | 81.52 | -2.57% | 13,924 |
The 2023 ETF Series Trust II - GMO U.S. Value ETF is an exchange traded fund launched and managed by Grantham Mayo Van Otterloo & Co. LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks companies across diversified market capitalization. It invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. It employs quantitative analysis to create its portfolio. The fund does not invest in stocks of companies operating across cluster munitions, mining and production of thermal coal sectors. The fund employs proprietary research to create its portfolio. The 2023 ETF Series Trust II - GMO U.S. Value ETF was formed on October 28, 2024 and is domiciled in the United States.